PSG interprets sleep by integrating signals rather than relying on a single measurement. EEG supplies information about brain activity, while EOG and EMG add eye-movement and muscle-activity patterns that help distinguish sleep stages. Respiratory, cardiac, and oxygenation measures then show how bodily events coincide with neural changes, allowing investigators to relate sleep architecture to brain-body regulation.
Sleep staging depends on the relationship among signals, not on EEG alone. EEG reflects changing brain activity, EOG identifies eye-movement patterns, and EMG indicates muscle activity. Examining these measures together helps separate stages that may look similar when considered through one channel, producing a more informative description of sleep architecture for neuroscience and clinical interpretation.
Respiratory and oxygenation channels connect sleep-related neural states with physiological consequences. Airflow shows breathing changes, respiratory effort indicates the work of breathing, and blood oxygen levels reveal whether an event affects oxygenation. Comparing these measures with the other PSG signals can expose abnormal episodes associated with sleep apnea and clarify how sleep disrupts body function.
In neuroscience, PSG provides an objective way to examine sleep architecture, neural regulation, and the relationship between sleep and disease. Because the recording includes brain and peripheral physiological signals, researchers can study whether changes in bodily function occur alongside altered sleep patterns. This makes PSG useful for linking measurable sleep phenomena with broader nervous-system questions.
An overnight PSG assessment combines sensor-derived recordings across the period when sleep naturally unfolds. The recorded channels may include EEG, EOG, EMG, heart rate, airflow, respiratory effort, and blood oxygen levels. Reviewing these signals together allows the assessment to characterize normal or disrupted sleep patterns instead of relying on one physiological measure.
PSG is particularly useful when clinicians need objective evidence about suspected sleep apnea, parasomnias, or movement disorders. The combined recording can reveal abnormal respiratory, movement-related, or sleep-pattern events that may not be captured by considering symptoms alone. Results help clinicians support diagnosis and select treatment plans grounded in measured overnight physiology.
PSG measurements can provide an objective outcome measure for sleep-related interventions and disease research. Investigators or clinicians can examine changes in sleep architecture, abnormal events, and associated physiological signals rather than relying only on impressions. This supports treatment evaluation and helps characterize how disease affects interactions between sleep, brain activity, and body function.